Trending/telomerase
Telomerase targeting drug demonstrates benefit in myelofibrosis treatment
ROCHESTER, Minn. — Imetelstat, a novel drug that targets telomerase, has demonstrated potential value in treating patients with myelofibrosis, according to the results of a…
No information found.
Special Topics
Sign up
Mayo Clinic Connect
An online patient support community